In Brief: Bayer
This article was originally published in The Tan Sheet
Executive Summary
Bayer: NDA for an undisclosed OTC non-steroidal anti-inflammatory drug was filed in the U.S. in "late 1994," according to the firm's recent annual report. The company also reported that clinical trials are continuing with Mycelex as an OTC short-course therapy...